Raghu P Kataru

Dr. Raghu P Kataru

Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2009 in Blood
Verified
Journal Article
Closed access
PDF file
RKRaghu P Kataru
Raghu P Kataru
KJKeehoon Jung
Keehoon Jung
CJCholsoon Jang
Cholsoon Jang
HYHanseul Yang
Hanseul Yang
RSReto A. Schwendener
Reto A. Schwendener
GKGou Young Koh
Gou Young Koh
Using a bacterial pathogen–induced acute inflammation model in the skin, we defined the roles of local lymphatic vessels and draining lymph nodes (DLNs) in antigen clearance and inflammation resolution. At the peak day of inflammation, robust expansion of lymphatic vessels and profound infiltration of CD11b+/Gr-1+ macrophages into the inflamed skin and DLN were observed. Moreover, lymph flow and inflammatory cell migration from the inflamed skin to DLNs were enhanced. Concomitantly, the expression of lymphangiogenic growth factors such as vascular endothelial growth factor C (VEGF-C), VEGF-D, and VEGF-A were significantly up-regulated in the inflamed skin, DLNs, and particularly in enriched CD11b+ macrophages from the DLNs. Depletion of macrophages, or blockade of VEGF-C/D or VEGF-A, largely attenuated these phenomena, and produced notably delayed antigen clearance and inflammation resolution. Conversely, keratin 14 (K14)–VEGF-C transgenic mice, which have dense and enlarged lymphatic vessels in the skin dermis, exhibited accelerated migration of inflammatory cells from the inflamed skin to the DLNs and faster antigen clearance and inflammation resolution. Taken together, these results indicate that VEGF-C, -D, and -A derived from the CD11b+/Gr-1+ macrophages and local inflamed tissues play a critical role in promoting antigen clearance and inflammation resolution.

1 January 2011 in Immunity
Verified
Journal Article
Closed access
RKRaghu P Kataru
Raghu P Kataru
HKHonsoul Kim
Honsoul Kim
CJCholsoon Jang
Cholsoon Jang
DCDong Kyu Choi
Dong Kyu Choi
BKBong Ihn Koh
Bong Ihn Koh
GKGou Young Koh
Gou Young Koh

3 March 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
HKHonsoul Kim
Honsoul Kim
RKRaghu P Kataru
Raghu P Kataru
GKGou Young Koh
Gou Young Koh
Lymphangiogenesis and lymphatic vessel remodeling are complex biological processes frequently observed during inflammation. Accumulating evidence indicates that inflammation-associated lymphangiogenesis (IAL) is not merely an endpoint event, but actually a phenomenon actively involved in the pathophysiology of various inflammatory disorders. The VEGF-C/VEGFR-3 and VEGF-A/VEGF-R2 signaling pathways are two of the best-studied pathways in IAL. Methods targeting these molecules, such as prolymphangiogenic or antilymphatic treatments, were found to be beneficial in various preclinical and/or clinical studies. This Review focuses on the most recent achievements in the fields of lymphatic biology relevant to inflammatory conditions. Additionally, preclinical and clinical therapies that modulate IAL are summarized.

29 January 2018 in Annual Review of Medicine
Verified
Journal Article
Closed access
JDJoseph Dayan
Joseph Dayan
CLCatherine Ly
Catherine Ly
RKRaghu P Kataru
Raghu P Kataru
Babak J. MehraraBabak J. Mehrara
Babak J. Mehrara
Lymphedema affects up to 1 in 6 patients who undergo treatment for a solid tumor in the United States. Its prevalence has increased as more effective oncologic therapies have improved patient survival, but there remains no definitive cure. Recent research has elucidated new details in the pathogenesis of the disease and has demonstrated that it is fundamentally an immunologic process that ultimately results in inflammation, fibroadipose deposition, impaired lymphangiogenesis, and dysfunctional lymphatic pumping. These findings have allowed for the development of novel medical and surgical therapies that may potentially alter the standard of care for a disease that has largely been treated by compression. This review seeks to provide an overview of the emerging therapies and how they can be utilized for effective management of lymphedema.

6 December 2019 in Science
Verified
Journal Article
Closed access
PDF file
SGShiri Gur-Cohen
Shiri Gur-Cohen
HYHanseul Yang
Hanseul Yang
SBSanjeethan C. Baksh
Sanjeethan C. Baksh
YMYuxuan Miao
Yuxuan Miao
JLJohn Levorse
John Levorse
EFElaine Fuchs
Elaine Fuchs
Stem cells reshape a lymphatic niche: Adult stem cells can both self-renew and regenerate new tissue upon demand. They reside in microenvironments (niches) that balance these decisions to avoid tissue overgrowth, cancer, and aging. Using murine skin as a model, Gur-Cohen et al. uncovered a lymphatic network of capillaries associated with the stem cell niche of hair follicles (see the Perspective by Harvey). Stem cells reshaped their lymphatic environment by switching their secretome to coordinate lymphatic-niche association. During tissue regeneration, a dynamic change in epithelial-lymphatic communication remodeled this association, synchronizing stem cell and niche behavior. Science , this issue p. 1218 ; see also p. 1193

Verified
Journal Article
Open access
PDF file
CLCatherine Ly
Catherine Ly
RKRaghu P Kataru
Raghu P Kataru
Babak J. MehraraBabak J. Mehrara
Babak J. Mehrara
Lymphedema results from lymphatic insufficiency leading to a progressive inflammatory process that ultimately manifests as discomfort, recurrent infections, and, at times, secondary malignancy. Collectively, these morbidities contribute to an overall poor quality of life. Although there have been recent advances in microsurgical interventions, a conservative palliative approach remains the mainstay of treatment for this disabling disease. The absence of a cure is due to an incomplete understanding of the pathophysiological changes that result in lymphedema. A histological hallmark of lymphedema is inflammatory cell infiltration and recent studies with animal models and clinical biopsy specimens have suggested that this response plays a key role in the pathology of the disease. The purpose of this report is to provide an overview of the ongoing research in and the current understanding of the inflammatory manifestations of lymphedema.